The interaction between the measles virus nucleoprotein and the Interferon Regulator Factor 3 relies on a specific cellular environment by Colombo, Matteo et al.
HAL Id: hal-02475099
https://hal.archives-ouvertes.fr/hal-02475099
Submitted on 6 Jul 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution| 4.0 International License
The interaction between the measles virus nucleoprotein
and the Interferon Regulator Factor 3 relies on a specific
cellular environment
Matteo Colombo, Jean-Marie Bourhis, Célia Chamontin, Carine Soriano,
Stéphanie Villet, Stéphanie Costanzo, Marie Couturier, Valérie Belle, André
Fournel, Hervé Darbon, et al.
To cite this version:
Matteo Colombo, Jean-Marie Bourhis, Célia Chamontin, Carine Soriano, Stéphanie Villet, et al.. The
interaction between the measles virus nucleoprotein and the Interferon Regulator Factor 3 relies on a
specific cellular environment. Virology Journal, BioMed Central, 2009, 6 (1), pp.59. ￿10.1186/1743-
422X-6-59￿. ￿hal-02475099￿
BioMed CentralVirology Journal
ssOpen AcceResearch
The interaction between the measles virus nucleoprotein and the 
Interferon Regulator Factor 3 relies on a specific cellular 
environment
Matteo Colombo1,2, Jean-Marie Bourhis1,3, Celia Chamontin4, 
Carine Soriano4, Stéphanie Villet4, Stéphanie Costanzo1, Marie Couturier1, 
Valérie Belle5, André Fournel5, Hervé Darbon1, Denis Gerlier*4 and 
Sonia Longhi*1
Address: 1Architecture et Fonction des Macromolécules Biologiques, UMR 6098 CNRS et Universités Aix-Marseille I et II, 163 Avenue de Luminy, 
Case 932, 13288 Marseille Cedex 09, France, 2Dept of Biomolecular Sciences and Biotechnology, Universita' degli Studi di Milano, Via Celoria, 
26. I-20133 Milan, Italy, 3Institut de Biologie et Chimie des Protéines, UMR 5086 CNRS Université de Lyon, 7, passage du Vercors, 69 367 Lyon 
cedex 7, France, 4VirPatH, FRE 3011, CNRS and Université Lyon 1, Faculté de Médecine RTH Laennec, 69372, Lyon, France and 5Bioénergétique 
et Ingénierie des Protéines, UPR 9036 CNRS, 31 Chemin Joseph Aiguier, 13402 Marseille Cedex, France, and Université Aix-Marseille I, 3 place 
Victor Hugo 13331, Marseille, Cedex 3, France
Email: Matteo Colombo - Matteo.Colombo@unimi.it; Jean-Marie Bourhis - Jean-Marie.Bourhis@ibcp.fr; 
Celia Chamontin - chamontin_celia@yahoo.fr; Carine Soriano - Carine.Soriano@univ-lyon1.fr; Stéphanie Villet - stephanie.villet@neuf.fr; 
Stéphanie Costanzo - Stephanie.Costanzo@afmb.univ-mrs.fr; Marie Couturier - Marie.Couturier@afmb.univ-mrs.fr; 
Valérie Belle - Belle@ibsm.cnrs-mrs.fr; André Fournel - Fournel@ibsm.cnrs-mrs.fr; Hervé Darbon - Herve.Darbon@afmb.univ-mrs.fr; 
Denis Gerlier* - Denis.Gerlier@univ-lyon1.fr; Sonia Longhi* - Sonia.Longhi@afmb.univ-mrs.fr
* Corresponding authors    
Abstract
Background: The genome of measles virus consists of a non-segmented single-stranded RNA molecule of negative
polarity, which is encapsidated by the viral nucleoprotein (N) within a helical nucleocapsid. The N protein possesses an
intrinsically disordered C-terminal domain (aa 401–525, NTAIL) that is exposed at the surface of the viral nucleopcapsid.
Thanks to its flexible nature, NTAIL interacts with several viral and cellular partners. Among these latter, the Interferon
Regulator Factor 3 (IRF-3) has been reported to interact with N, with the interaction having been mapped to the
regulatory domain of IRF-3 and to NTAIL. This interaction was described to lead to the phosphorylation-dependent
activation of IRF-3, and to the ensuing activation of the pro-immune cytokine RANTES gene.
Results: After confirming the reciprocal ability of IRF-3 and N to be co-immunoprecipitated in 293T cells, we thoroughly
investigated the NTAIL-IRF-3 interaction using a recombinant, monomeric form of the regulatory domain of IRF-3. Using
a large panel of spectroscopic approaches, including circular dichroism, fluorescence spectroscopy, nuclear magnetic
resonance and electron paramagnetic resonance spectroscopy, we failed to detect any direct interaction between IRF-3
and either full-length N or NTAIL under conditions where these latter interact with the C-terminal X domain of the viral
phosphoprotein. Furthermore, such interaction was neither detected in E. coli nor in a yeast two hybrid assay.
Conclusion: Altogether, these data support the requirement for a specific cellular environment, such as that provided
by 293T human cells, for the NTAIL-IRF-3 interaction to occur. This dependence from a specific cellular context likely
reflects the requirement for a human or mammalian cellular co-factor.
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Measles virus (MeV) is an enveloped RNA virus within the
Morbillivirus genus of the Paramyxoviridae family. Its non-
segmented, negative-sense, single-stranded RNA genome
is encapsidated by the viral nucleoprotein (N) within a
helical nucleocapsid. Transcription and replication are
carried out onto this N:RNA complex by the viral
polymerase complex which consists of two components,
the large protein (L) and the phosphoprotein (P)
(reviewed in [1]).
MeV N consists of two regions: a structured N-terminal
moiety, NCORE (aa 1–400), which contains all the regions
necessary for self-assembly and RNA-binding [2,3], and a
C-terminal domain, NTAIL(aa 401–525) that is intrinsi-
cally unstructured [4] and is exposed at the surface of the
viral nucleocapsid [2,5,6].
Intrinsically disordered proteins (IDPs) or protein
domains lack highly populated and uniform secondary
and tertiary structure under physiological conditions but
fulfill essential biological functions [7-19]. Since NTAIL is
intrinsically flexible and is exposed at the surface of the
viral nucleocapsid, it interacts with various partners,
including the viral P protein [3,4] and host cell proteins
such as the major inducible heat shock protein (Hsp72)
[20,21], and the yet uncharacterized Nucleoprotein
Receptor (NR) [22,23]. In addition, it has also been
reported to interact with the Interferon Regulator Factor 3
(IRF-3) [24].
IRF-3 is ubiquitously expressed as a stable latent transacti-
vator of the cellular innate immune response [25]. It
belongs to the family of interferon regulatory factors (IRF)
and acts as a transactivator for the interferon-β (IFN-β)
and various pro-inflammatory cytokine genes. All mam-
malian IRFs share a conserved N-terminal DNA binding
domain (DBD) and a C-terminal interferon association
domain (IAD). IRF-3 consists of a DBD (aa 1–110), of a
proline-rich region (PRR, aa 112–174), followed by the
IAD (aa 175–384) and by a serine-rich region (SRR, aa
385–427) (Figure 1A).
The seminal and unique observation that MeV N activates
IRF-3 to induce CCL5 (also called RANTES), a pro-inflam-
matory cytokine, but not IFN-β, was done by the Hiscott's
group ?[24]. After MeV infection, IRF-3 was phosphor-
ylated at the key Ser385 and Ser386 residues, and this form
was able to bind to the interferon sensitive response ele-
ment of ISG15 in complex with CREB binding protein in
vitro. Activation of IRF-3, which required active MeV tran-
scription, was also mimicked by the transient expression
of the N protein [24]. Moreover, IRF-3 and a cellular
kinase could be co-immunoprecipitated with N [24].
From these data it was assumed that MeV N physically
interacts with IRF-3 and induces the phosphorylation of
the latter by recruiting the kinase. Phosphorylation of IRF-
3 would then lead to IRF-3 homo-dimerisation, followed
by IRF-3 nuclear import and transactivation of a selective
set of pro-inflammatory cytokines [24]. Using deletion
constructs and co-immunoprecipitation studies, the IRF-3
binding region was grossly mapped to NTAIL (residues
415–523), while the N binding region within IRF-3 was
mapped to residues 198–394 [24].
We have previously reported that NTAIL undergoes α-heli-
cal induced folding upon binding to P [4], and solved the
crystal structure of the P domain (XD, aa 459–507)
responsible for the NTAIL induced folding [26]. Within a
conserved region of NTAIL (aa 489–506, Box2), we have
identified an α-helical molecular recognition element (α-
MoRE, aa 489–499) [27], involved in the binding to XD
and in induced folding [26,28-30]. XD-induced α-helical
folding of the NTAIL region encompassing residues 486–
503 was confirmed by Kingston and co-workers, who
solved the crystal structure of a chimeric construct consist-
ing of XD and the 486–504 region of NTAIL [31]. Analysis
of this structure revealed that the α-helix of NTAIL is
embedded in the hydrophobic cleft of XD delimited by
helices α2 and α3, to form a pseudo-four helix arrange-
ment that is very frequently found in nature [31].
Analysis of the crystal structure of the regulatory domain
(RD, aa 175–427) of IRF-3 (IRF-3 RD, pdb code 1QWT,
[32]) (Figure 1B) points out the presence of a triple α-hel-
ical bundle well superimposable to the structure of XD
(Figure 1C). Furthermore, the triple α-helical bundle of
IRF-3 also accommodates the nuclear co-activator binding
domain (or IbiD domain) of CREB (pdb code 1ZOQ,
[33], data not shown), which forms a disordered molten
globule in the absence of a binding partner [34] and that
folds into an α-helical structure upon binding to IRF-3
[33]. We therefore hypothesized that the α-helical bundle
of IRF-3 may support the ability of IRF-3 to interact with
the disordered NTAIL domain in a way reminiscent of that
of XD.
After confirming the reciprocal ability of IRF-3 and N to be
co-immunoprecipitated in human cells, we undertook the
cloning and the bacterial expression of IRF-3 RD in view
of obtaining conspicuous protein amounts suitable for
further biochemical and biophysical studies aimed at
investigating the molecular mechanisms of the NTAIL-IRF-
3 interaction. A monomeric form of IRF-3 RD was then
purified from the soluble fraction of E. coli, and further
used in experiments aimed at ascertaining whether NTAIL
underwent induced folding upon binding to IRF-3. Using
a panel of spectroscopic approaches, including circular
dichroism (CD), fluorescence spectroscopy, nuclear mag-
netic resonance (NMR) and electron paramagnetic reso-Page 2 of 17
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(A) Schematic representation of the modular organization of IRF-3Figure 1
(A) Schematic representation of the modular organization of IRF-3. (B) Ribbon representation of the crystal struc-
ture of IRF-3 RD (pdb code 1QWT) in which the side chains of trp residues are shown in sticks and in dark grey. (C) Superim-
position between the crystal structure of IRF-3 RD (light grey) and XD (dark grey, pdb code 1OKS).
Virology Journal 2009, 6:59 http://www.virologyj.com/content/6/1/59nance (EPR) spectroscopy, we failed to document a direct
binding of NTAIL with IRF-3 RD, under conditions where
the NTAIL-XD interaction was detected. Moreover, the lack
of direct interaction of IRF-3 with the full-length N pro-
tein ruled out a possible contribution of the folded NCORE
domain of N (aa 1–400) in the interaction with IRF-3.
Strikingly, the interaction could not be detected in the
bacterial lysate either, nor was it observed using a yeast
two hybrid assay. Altogether these results support the
requirement of a specific cellular environment for the
NTAIL-IRF-3 interaction to occur.
Methods
Bacterial strains, primers, restriction enzymes and 
antibodies
The E. coli strains DH5α (Stratagene) or Rosetta [DE3]
pLysS (Novagen) were used for selection and amplifica-
tion of DNA constructs, or for the expression of recom-
binant proteins, respectively.
Primers were from Invitrogen and Operon. Restriction
enzymes, anti-flag mAb, and goat anti-mouse HRP conju-
gated secondary antibodies were purchased from New
England Biolabs, Sigma, and Upstate Laboratories, respec-
tively.
Co-immunoprecipitation of proteins expressed in human 
cells
The pCDNA-myc-IRF3 and pEF-BOS-flag-N eukaryotic
vectors were derived by PCR and subcloning into a home-
made pCDNA-myc and pEF-BOS-flagx2 vector so as to
encode N-terminal myc- and flag- tagged IRF-3 and N pro-
tein, respectively. 293T cells (2 × 106) were cotransfected
with 12 μg of plasmid DNA using Dreamfect-Gold reagent
according to OZ BIOSCIENCES' instructions http://
www.ozbiosciences.com/dreamfect.html. Two days after,
cells were collected and lysed in 0.3 ml of lysis buffer (50
mM Tris pH 8.0, 5 mM EDTA, 150 mM NaCl, 0.5% Igepal
CA-630 (Sigma), 1 mM phenyl-methyl-sulphonyl-fluo-
ride (PMSF) and 1× Complete® (Roche) by 3 passages into
a 26G needle for 30 min on ice. Cell debris were elimi-
nated by centrifugation at 15,000 rpm for 15 min. Then,
proteins were immunoprecipitated using rabbit anti-IRF-
3 (Santa-Cruz) and protein-G-Sepharose® (GE Healthcare
Life Sciences) beads and eluted as detailed elsewhere [35].
Alternatively, they were immunoprecipitated using Mon-
oclonal ANTI-FLAG® M2 Affinity Gel and eluted using 3X
FLAG® Peptide according to Sigma's instructions. Proteins
were then detected by western blotting using the appropri-
ate antibody and peroxydase-conjugate combinations as
detailed elsewhere [35].
Cloning of human IRF-3 cDNA
The cDNA of human IRF3 was obtained by RT-PCR from
total RNA extracted from HeLa cells. The RNA extraction
method and the RT-PCR were performed as described
elsewhere [36]. The IFR-3 cDNA was PCR amplified using
forward 5'-CATGAATTCATGGGAACCCCAAAGCCA-3'
and backward 5'-TGACTCGAGTCAGCTCTCCCCAG-
GGCC-3' primers containing EcoRI and XhoI restriction
sites (bold), respectively. The cDNA was subcloned down-
stream the myc tag into an in-house made pcDNA3-myc
plasmid. The myc-IRF-3 construct was checked by
sequencing.
Construction of IRF-3 RD expression plasmids
The IRF-3 RDHN, IRF-3 RDFN and IRF-3 RDHC gene con-
structs, encoding residues 175–427 of the IRF-3 protein
with either an hexahistidine tag fused to the N-terminus
(IRF-3 RDHN) or to the C-terminus (IRF-3 RDHC), or with
a flag sequence (DYKDDDDK) [37] fused to the N-termi-
nus (IRF-3 RDFN), were obtained by recursive PCR, using
pIRF-3 as template and Pfx polymerase (Invitrogen).
Primers were designed to introduce either a hexahistidine
tag encoding sequence (either at the N- or at the C-termi-
nus of IRF-3 RD) or a flag encoding sequence at the N-ter-
minus of IRF-3 RD, as well as an AttB1 and an AttB2 site
allowing further cloning into the pDest14 vector (Invitro-
gen) using the Gateway recombination system (Invitro-
gen). The sequence of the coding region of all the
pDest14/IRF-3 RD constructs was checked by sequencing
(GenomeExpress).
XD, N and NTAIL expression plasmids
The following constructs have already been described: (i)
the pDest14/XDHC gene construct, encoding residues
459–507 of the MeV P protein (strain Edmonston B) with
a hexahistidine tag fused to its C-terminus, [26], (ii) the N
gene construct, pet21a/NFNHC, encoding the MeV N pro-
tein (strain Edmonston B) with a flag fused at its N-termi-
nus and an hexahistidine tag fused to its C-terminus, [2],
(iii) the pDest14/NTAILHN, encoding residues 401–525 of
the wt MeV N protein (strain Edmonston B) with an N-ter-
minal hexahistidine tag [38], and (iv) the NTAIL S407C,
NTAIL L496C and NTAIL V517C gene constructs, encoding
residues 401–525 of the MeV N protein with a Cys substi-
tution at positions 407, 496 and 517 of N, respectively,
and with a N-terminal hexahistidine tag [29].
The pDest14/NTAILFN construct, encoding residues 401–
525 of the wt MeV N protein (strain Edmonston B) with
an N-terminal flag sequence (NTAILFN), was obtained by
recursive PCR followed by cloning into the pDest14 vec-
tor. PCR was carried out using pDest14/NTAILHN [38] as
template, and Pfu polymerase (Promega). Beyond AttB1
and AttB2 sites, primers were designed to introduce a flag
encoding sequence at the N-terminus of NTAIL. The coding
regions of the NTAILFN construct was checked by sequenc-
ing (GenomeExpress).Page 4 of 17
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The E. coli strain Rosetta [DE3] (Novagen) was used for
the expression of the pDest14/IRF-3 RD constructs. Cul-
tures were grown overnight to saturation in Luria-Bertani
medium containing 100 μg/ml ampicilin and 17 μg/ml
chloramphenicol. An aliquot of the overnight culture was
diluted 1/12.5 in LB medium and grown at 37°C. At
OD600 of 0.7, the culture was incubated in ice for 2 hours.
Then isopropyl β-D-thiogalactopyranoside (IPTG) and
ethanol were added to a final concentration of 50 μM and
2% (v/v), respectively. Cells were grown at 17°C for 16
hours. The induced cells were harvested, washed and col-
lected by centrifugation. The resulting pellets were frozen
at -20°C.
Isotopically substituted (15N) NTAIL and (15N) IRF-3 RD
were prepared by growing bacteria transformed by the
pDest14/NTAILHN and pDest14/IRF-3RDHN constructs,
respectively, in minimal M9 medium supplemented with
15NH4Cl (0.8 g/l) [38]. Expression of tagged XD (XDHC)
[26], tagged N [2],wt and cys-substituted NTAIL [4,29,38]
proteins was carried out as already described.
Purification of recombinant proteins
Cellular pellets from bacteria transformed with the
pDest14/IRF3-RDHN expression plasmid were resus-
pended in 5 volumes (v/w) buffer A (50 mM sodium
phosphate pH 8, 300 mM NaCl, 10 mM Imidazole, 1 mM
PMSF supplemented with lysozyme 0.1 mg/ml, DNAse I
10 μg/ml, protease inhibitor cocktail (Complete ® Roche)
(one tablet per 50 ml of lysis buffer). After a 20 min incu-
bation with gentle agitation, the cells were disrupted by
sonication (using a 750 W sonicator and 4 cycles of 30 s
each at 60% power output). The lysate was clarified by
centrifugation at 30,000 g for 30 min. Starting from one
liter of culture, the clarified supernatant was incubated for
1 h with 4 ml Talon resin (Clontech), previously equili-
brated in buffer A. The resin was washed with buffer A,
and the IRF-3 RD protein was eluted in buffer A contain-
ing 250 mM imidazole. Eluates were analyzed by SDS-
PAGE for the presence of the desired product. The frac-
tions containing the recombinant product were com-
bined, dialyzed against buffer B (20 mM Tris/HCl pH 7.4,
10 mM NaCl, 0.1 mM EDTA, 1 mM DTT) and then loaded
onto a Hi-Trap Q Fast-Flow 5 × 1 column (GE Health-
care). The protein was eluted with a NaCl gradient (from
25 to 250 mM). The fractions containing the protein were
combined and concentrated using 10 kDa molecular cut-
off Centricon Plus-20 (Millipore) prior to loading onto a
Superdex 200 HR 10/30 column (GE Healthcare) fol-
lowed by elution in various buffers. After elution with
buffer C (20 mM Hepes pH 7.3, NaCl 100 mM, EDTA 0.1
mM), the fractions corresponding to IRF3 were collected
and dialyzed against buffer D (20 mM Hepes pH 7.3,
NaCl 10 mM, EDTA 0.1 mM). The purified protein,
referred to as IRF-3 RD, was stored at -20°C.
Purification of histidine-tagged N, XD and of wt or cys-
substituted NTAIL proteins was carried out as described in
[2,26,29,30,38].
All purification steps, except for gel filtrations, were car-
ried out at 4°C. Protein concentrations were calculated
using OD280 measurements and the theoretical absorp-
tion coefficients ε (mg/ml.cm) at 280 nm as obtained
using the program ProtParam at the EXPASY server http:/
/www.expasy.ch/tools. Apparent molecular mass of pro-
teins eluted from gel filtration columns was deduced from
a calibration carried out with Low Molecular Weight
(LMW) and High Molecular Weight (HMW) calibration
kits (GE Healthcare). The theoretical Stokes radius (Rs) of
a native (RsN) protein was calculated according to [39]:
log(RsN) = 0.369*log(MM) - 0.254, with (MM) being the
molecular mass (in Daltons) and RS being expressed in Å.
Analytical size-exclusion chromatography (SEC) with on-
line multi-angle laser light-scattering, absorbance, and 
refractive index (MALS/UV/RI) detectors
SEC was carried out on a HPLC system (Alliance 2695,
Waters) using a Superose 12 column (5 ml) (Amersham,
Pharmacia Biotech) eluted with various buffers at a flow
of 0.5 ml/min. Detection was performed using a triple-
angle light-scattering detector (MiniDAWN™ TREOS,
Wyatt Technology), a quasi-elastic light-scattering instru-
ment (Dynapro™, Wyatt Technology) and a differential
refractometer (Optilab® rEX, Wyatt Technology). Molecu-
lar mass and hydrodynamic radius (Stokes radius, RS)
determination was performed by the ASTRA V software
(Wyatt Technology) using a dn/dc value of 0.185 ml/g.
IRF-3 RD was loaded at a final concentration ranging from
0.2 mM to 1.2 mM.
Dynamic Light Scattering (DLS)
Dynamic light scattering experiments were performed
with a Nano-S Zetasizer (MALVERN) at 20°C. All samples
were filtered prior to the measurements (Millex syringe fil-
ters 0.22 μm, Millipore). The hydrodynamic radius was
deduced from translational diffusion coefficients using
the Stokes-Einstein equation. Diffusion coefficients were
inferred from the analysis of the decay of the scattered
intensity autocorrelation function. All calculations were
performed using the software provided by the manufac-
turer.
Mass Spectrometry (MALDI-TOF)
Mass analysis of tryptic fragments was carried out using an
Autoflex mass spectrometer (Bruker Daltonics). 1 μg of
purified IRF-3 RD obtained after separation onto 12%
SDS-PAGE was digested with 0.25 μg trypsin. The experi-Page 5 of 17
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pared to theoretical values found in protein data base
http://www.matrixscience.com. The mass standards were
either autolytic tryptic peptides or peptide standards
(Bruker Daltonics).
Spin labeling and EPR spectroscopy
Spin labeling of cysteine-substituted NTAIL variants was
carried out as already described [29,30]. EPR spectra were
recorded at room temperature on an ESP 300E Bruker
spectrometer equipped with an ELEXSYS Super High Sen-
sitivity resonator operating at 9.9 GHz. Samples were
injected in a quartz capillary, whose sensitive volume was
about 20 μl. The microwave power was 10 mW and the
magnetic field modulation frequency and amplitude were
100 kHz and 0.1 mT, respectively. Spectra were recorded
in buffer D. The concentration of spin-labeled NTAIL vari-
ants was 20 μM, while that of IRF-3 RD was 80 μM.
Circular Dichroism
Circular dichroism (CD) spectra were recorded on a Jasco
810 dichrograph using 1 mm thick quartz cells at 20°C.
All spectra were recorded in 10 mM sodium phosphate
buffer pH 7.0.
CD spectra were measured between 185 and 260 nm, at
0.2 nm/min and were averaged from three independent
acquisitions. The spectra were corrected for water signal
and smoothed by using a third-order least square polyno-
mial fit. Protein concentrations of 0.1 mg/ml were used.
Mean ellipticity values per residue ([Θ]) were calculated as
[Θ] = 3300 m ΔA/(l c n), where l (path length) = 0.1 cm,
n = number of residues, m = molecular mass in daltons
and c = protein concentration expressed in mg/ml.
Structural variations of NTAIL upon addition of IRF-3 RD
were measured as a function of changes in the initial CD
spectrum upon addition of two-fold molar excess of IRF-
3 RD. XD was used as a positive control.
The number of residues (n) is 132 for NTAILHN, 260 for
IRF-3 RD, and 56 for XD, while m values are 14,632 Da for
NTAILHN, 28,903 Da for IRF-3 RD, and 6, 686 Da for XD.
In the case of protein mixtures, mean ellipticity values per
residue ([Θ]) were calculated as [Θ] = 3300 ΔA/{[(C1 n1)/
m1) + (C2 n2/m2)] l}, where l (path length) = 0.1 cm, n1 or
n2 = number of residues, m1 or m2 = molecular mass in
daltons and c1 or c2 = protein concentration expressed in
mg/ml for each of the two proteins in the mixture. The
average ellipticity values per residue ([Θ]Ave), were calcu-
lated as follows: [Θ]Ave = [([Θ]1 n1) + ([Θ]2 n2R)]/(n1 + n2
R), where [Θ]1 and [Θ]2 correspond to the measured mean
ellipticity values per residue, n1 and n2 to the number of
residues for each of the two proteins, and R to the excess
molar ratio of protein 2. The experimental data in the
185–260 nm range were treated using the CDNN software
package, which allowed estimation of the α-helical con-
tent.
Fluorescence spectroscopy
Fluorescence intensity variations of IRF-3 RD tryptophans
were measured by using a Cary Eclipse (Varian) equipped
with a front-face fluorescence accessory at 20°C, by using
2.5 nm excitation and 10 nm emission bandwidths. The
excitation wavelength was 290 nm and the emission spec-
tra were recorded between 300 and 450 nm. Titrations
were performed in a 1 ml quartz fluorescence cuvette con-
taining 1 μM IRF-3 RD in buffer D, and by gradually
increasing the concentration of NTAIL from 10 nM to 1 μM.
Experimental fluorescence intensities were corrected by
subtracting the spectrum obtained with NTAIL protein
alone (note that NTAIL is devoid of tryptophan residues).
Data were analyzed by plotting the relative fluorescence
intensities at the maximum of emission at increasing NTAIL
concentrations.
Two-dimensional Heteronuclear Magnetic Resonance
2D-HSQC spectra [40] were recorded on a 600-MHz ultra-
shielded-plus Avance-III Bruker spectrometer equipped
with a TCI cryo-probe. The temperature was set to 300 K
and the spectra were recorded with 2048 complex points
in the directly acquired dimension and 128 points in the
indirectly detected dimension, for 6 h each. Solvent sup-
pression was achieved by the WATERGATE 3–9–19 pulse
[41]. The data were processed using the TOPSPIN soft-
ware, and were multiplied by a sine-squared bell and zero-
filled to 1k in first dimension with linear prediction prior
to Fourier transform.
The samples were (i) a 25 μM uniformly 15N-labeled
NTAILHN either alone or after addition of a 4-fold molar
excess of IFR-3 RD, and (ii) a 25 μM uniformly 15N-
labeled IRF-3 RD either alone or after addition of a 2-fold
molar excess of full-length N. Spectra were recorded in
buffer D containing 10% D2O (v/v).
Co-immunoprecipitation of proteins expressed in bacteria
Twenty to 80 ml aliquots of induced bacterial cultures
expressing either NTAIL or IRF-3 RD, were harvested,
washed, collected by centrifugation and the resulting pel-
lets were frozen at -20°C. Aliquots were individually
resuspended in 500 μl of buffer C supplemented with 1
mM PMSF, 0.1 mg/ml lysozyme, 10 μg/ml DNAse I, and
protease inhibitor cocktail (Complete ® Roche). Bacterial
lysates were sonicated (using a 750 W sonicator and 3
cycles of 7 s at 35% power output) and were clarified by
centrifugation at 16,000 g for 20 min at 4°C. The super-
natants, were recovered and filtered onto 0.45 μm Ultra-
free-MC centrifugal filter devices (Millipore).Page 6 of 17
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Virology Journal 2009, 6:59 http://www.virologyj.com/content/6/1/59Fifty to 100 μl of a bacterial lysate expressing a flagged
protein (NTAIL or IRF-3 RD, lysate A) were mixed with 60μg of an anti-flag monoclonal antibody (Sigma-Aldrich),
15 μl of Protein A-Sepharose CL 4B (GE Healthcare) (pre-
viously equilibrated with 10 volumes of buffer C), and
buffer C up to a final volume of 400 μl to increase the vol-
ume during the binding step. After 1 h incubation at 4°C
with gentle agitation, the flow-through was recovered and
the resin was washed twice with 20 bed volumes of buffer
C. Fifty μl of either a bacterial lysate expressing an
unflagged protein (NTAIL, lysate B) or of buffer C contain-
ing 5 μg of purified unflagged XD (protein B), both corre-
sponding to stoichiometric amounts, were added to the
resin and incubation was carried out for one additional
hour. The flow-through, containing the unretained frac-
tion, and the resin were recovered and analyzed by SDS-
PAGE. The NTAIL-XD couple was used as the positive con-
trol. Additional controls included incubation of the
immobilized immunoaffinity chromatography (IIAC)
resin with either lysates A or lysates/proteins B alone (data
not shown). The identity of the co-precipitated or unre-
tained protein bands was confirmed by mass-spectrome-
try.
Yeast two-hybrid assay
The following constructs were made by PCR amplification
using the pGBKT7-NTAIL plasmid [42] as a template: MeV
NTAIL (N 401–525), NTAILΔ1 (N 421–525), NTAILΔ2,3 (N
401–488), NTAILΔ3 (N 401–516). They were cloned in-
frame downstream the GAL4 DNA-binding domain of the
pLexAGagB vector (Aptanomics) thus yielding BD-bait
fusion proteins named BD-NTAIL, BD-NTAILΔ1, BD-
NTAILΔ2,3, BD-NTAILΔ3. PCT (P 231–507) from pGBKT7-
PCT plasmid [42] and IRF-3 from pcDNA3-myc-IRF-3
were cloned in-frame downstream the GAL4-activating
domain of the vector pWP2C (Aptanomics) to yield the
AD-PCT and AD-IRF3 proteins, respectively. The pLexA
(no protein in fusion, Ø), pWP2::RG22C anti-LexA (Ctr+)
and pWP2::C5C (Ctr-) plasmids (Aptanomics) were used
as controls. All plasmids were checked by sequencing.
MB226α (Leu-Trp-His-Ade-) yeast cells transformed with
the BD-bait and pSH1834 (coding for β-galactosidase as
reporter gene) vectors, and MB210a (MATα, Leu-Trp-His-
Ade-) yeast cells transformed with the AD-prey vectors,
were selected on histidine + uracile (SD/-His-Ura), and
tryptophan (SD/-Trp) deficient SD medium, respectively.
Transformed MB226α and MB210a cells were mated and
grown on Glucose -His-Ura-Trp+X-Gal for successful mat-
ing with replicate on Galactose/Raffinose -His-Ura-Trp+X-
Gal for testing the interaction between baits and preys.
Experiments were repeated two times. Expression of bait
and prey fusion were verified by western blot using anti-
HA monoclonal antibody as described previously [42].
Results
Reciprocal coimmunoprecipitation of myc-IRF-3 and flag-
N proteins
When co-expressed in human 293T cells, flag-N and myc-
IRF3 formed complexes that could be co-immunoprecipi-
tated by either anti-Flag or anti-IRF-3 antibodies (Figure
2). However, the amount of N found in the anti-IRF-3
immunoprecipitate was rather limited, since it was
detected only after overexposure of the western blot, a
condition where the N signal immunoprecipitated by
anti-Flag antibodies is very intense. As controls N and P
proteins were readily co-immunoprecipitated, while no
myc-IRF3/P complex was detected, thus ruling out the
possibility that IRF-3 might be aspecifically retained onto
the resin (data not shown). Cells expressing myc-IRF3
were used to ascertain antibody specificity in the western
blot assay. These results thus confirm those previously
obtained by ten Oever et al [24]
Domain analysis of IRF-3 and subcloning of the IRF-3 gene 
fragment encoding the regulatory domain (RD)
IRF-3 has a modular organization (see Figure 1A), with
the NTAIL binding region having been mapped to residues
198–384 [24]. Since the IRF-3 region encompassing resi-
dues 175–427 (herein referred to as regulatory domain,
RD) was successfully purified from the soluble fraction of
Reciprocal coimmunoprecipitation of myc-IRF-3 and flag-N proteinsFigure 2
Reciprocal coimmunoprecipitation of myc-IRF-3 and 
flag-N proteins. Flag-N was co-expressed with myc-IRF3 in 
293T cells and immunoprecipitated by either anti-flag mAb 
or rabbit polyclonal anti-IRF3 antibodies. After elution by 
Flagx3 peptide or Laemli buffer, immunoprecipitated proteins 
were analysed by Western Blotting using either anti-flag or 
anti-myc mAb. Note that the western blot was overexposed 
so as to reveal flag-N co-immunoprecipitated with myc-IRF-3
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Virology Journal 2009, 6:59 http://www.virologyj.com/content/6/1/59E. coli and further crystallized [32], we cloned the DNA
fragment of the IRF-3 gene encoding RD into the pDest14
expression plasmid. The resulting constructs encode RD
with either an N-terminal or a C-terminal histidine tag.
Expression and purification of a stable, monomeric form of 
IRF-3 RD
While the construct encoding IRF-3 RD with a histidine-
tag at the C-terminus was poorly expressed and mostly
insoluble upon induction at 17°C (data not shown), the
construct bearing the histidine-tag at the N-terminus was
well expressed and its solubility was estimated to be
approximately 50% (Figure 3A). IRF-3 RD was purified to
homogeneity (> 95%) in 3 steps: immobilized metal
affinity chromatography (IMAC), ion exchange chroma-
tography (IEC) and gel filtration (Figure 3A). The identity
of the recombinant product was confirmed by mass spec-
trometry analysis of the tryptic fragments obtained after
digestion of purified IRF-3 RD.
IRF-3 was reported to undergo dimerization upon phos-
phorylation induced by MeV N [24,32]. We indeed found
that purified, recombinant IRF-3 RD is a dimer under var-
ious buffer conditions, including 10 mM sodium phos-
phate pH 7 or buffer A (data not shown). Since IRF-3
dimerization is the result of a cascade of events triggered
by the initial binding of N, we reasoned that the dimeric
form of IRF-3 might in principle be expected to exhibit a
reduced ability to bind to N. In support of this hypothesis,
heteronuclear NMR, EPR and fluorescence experiments
carried out with a dimeric form of IRF-3 RD, showed no
detectable interaction with NTAIL (data not shown).
We therefore screened various combinations of buffers,
ionic strengths and salt concentrations in order to identify
conditions where IRF-3 RD is a stable monomer. We used
SEC-MALS to assess the oligomeric state of purified IRF-3
RD in various buffers. The experimentally observed RS of
IRF-3 RD at 0.2 mM in 20 mM Hepes pH 7.3, NaCl 100
mM, EDTA 0.1 mM (buffer C) was 2.7 nm (Figure 3B),
which corresponds to the theoretical value expected for a
monomer (approximately 2.5 nm) [39]. Moreover, the
sharpness and symmetry of the peak indicates the pres-
ence of a well-defined molecular species, thus pointing
out the homogeneity of the protein sample. Notably, in
these buffer conditions, the protein was found to be mon-
omeric in the 0.2–1.2 mM concentration range, thus rul-
ing out a possible effect of sample concentration on
oligomerization. DLS analysis showed that the protein
remains monomeric in the 0.2–1.2 mM range also after
lowering the salt concentration to 10 mM (buffer D). Sta-
bility and homogeneity of the sample in buffer D upon
prolonged storage at -20°C were checked by DLS. As the
oligomeric state of IRF-3 RD was affected by pH and
buffer, all subsequent studies, with the only exception of
CD experiments, were carried out in buffer D.
Analysis of the NTAIL-IRF-3 RD interaction by circular 
dichroism
To ascertain that the purified IRF-3 RD protein was prop-
erly folded, we recorded its far-UV CD spectrum. Because
of significant absorption of buffer D resulting in highly
noisy spectra, the protein (200 μM in buffer D) was
diluted to a final concentration of 0.1 mg/ml (3.5 μM) in
10 mM sodium phosphate buffer pH 7. Since the protein
was diluted more than 50 times, dimerization under these
conditions was assumed to be unlikely. The far-UV CD
spectrum of IRF-3 RD (Figure 4A, grey line) is typical of a
structured protein with a predominant α-helical content,
as indicated by the positive ellipticity between 185 and
200 nm, and by the two minima at 208 and 222 nm. The
calculated helicity (28.5%), as obtained using the CDNN
Purification of IRF-3 RD from E. coliFigure 3
Purification of IRF-3 RD from E. coli. (A) Coomassie 
blue staining of a 15% SDS-PAGE. TF: bacterial lysate (total 
fraction); SN: clarified supernatant (soluble fraction); IMAC: 
eluent from Immobilized Metal Affinity Chromatography; 
HITRAP: eluent from Ion Exchange Chromatography. GF: 
eluent from Gel Filtration. (B) Elution profile of IRF-3 RD 
from analytical SEC-MALS in buffer C. The peak containing 
IRF-3 RD is highlighted and the inferred RS is also shown.
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Virology Journal 2009, 6:59 http://www.virologyj.com/content/6/1/59software, is in agreement with the α-helical content
(26.1%) derived from the analysis of the crystal structure
of IRF-3 RD (pdb code 1QWT), thus indicating that the
recombinant IRF-3 RD protein is properly folded.
We next addressed the question as to whether IRF-3 RD is
able to induce α-helical folding of NTAIL, as already
reported for XD [26]. We therefore, recorded the far-UV
CD spectrum of NTAIL in the presence of a two-fold molar
excess of IRF-3 RD (Figure 4A), a condition where XD
induces α-helical folding of NTAIL (Figure 4B). The far-UV
CD spectrum of XD (Figure 4B, grey line) is typical of a
structured protein with a predominant α-helical content.
After mixing NTAIL with a two-fold molar excess of XD, the
observed CD spectrum differs from the corresponding
average curve calculated from the two individual spectra
(Figure 4B). Since the average curve corresponds to the
spectrum that would be expected if no structural varia-
tions occur, deviations from this curve indicate structural
transitions. The observed deviations are consistent with
an XD-induced α-helical transition of NTAIL, as judged by
the much more pronounced minima at 208 and 222 nm,
and by the higher ellipticity at 190 nm of the experimen-
tally observed spectrum compared to the corresponding
average curve (Figure 4B) [26]. Contrary to XD, the exper-
imentally observed CD spectrum of a mixture containing
NTAIL and a two-fold molar excess of IRF-3 RD very well
superimposes onto the average spectrum, thus indicating
that NTAIL undergoes little, if any, structural transitions in
the presence of IRF-3 RD (Figure 4A). A further increase in
the molar excess of IRF-3 RD resulted in strong dampen-
ing of the NTAIL signal due to the larger protein size of IRF-
3 RD (28 kDa) as compared to NTAIL (14.6 kDa) (data not
shown). Increasing the NTAIL molar excess did not result in
any detectable structural transitions either (data not
shown).
Analysis of the NTAIL-IRF-3 RD interaction by 
heteronuclear NMR spectroscopy
We next carried out heteronuclear NMR experiments
which allowed the use of buffer D, a condition where IRF-
3 RD is monomeric, as well as higher concentrations (100
μM) of the protein partner. The HSQC spectrum of 15N
uniformly labeled NTAIL either alone (25 μM) or in the
presence of a four-fold molar excess of unlabeled IRF-3
RD was recorded. The very low spread of the resonance
frequencies of NTAIL was typical of a disordered protein
devoid of stable, highly populated secondary structure
(Figure 5A) (see also [4,38]). The HSQC spectrum
obtained in the presence of a molar excess of unlabeled
IRF-3 RD, pretty well superimposes onto that of NTAIL
alone, thus pointing out that the 15N and 1HN resonance
Analysis of NTAIL structural transitions in the presence of IRF-3 RD or XD by far-UV CDFigure 4
Analysis of NTAIL structural transitions in the presence of IRF-3 RD or XD by far-UV CD. Far-UV CD spectra of 
NTAIL alone (black line) or in the presence of a two-fold molar excess of IRF-3 RD (A) or XD (B). Spectra were recorded in 
10 mM sodium phosphate buffer at pH 7. In the mixture containing NTAIL + IRF-3 RD, the concentration of NTAIL is 1.4 μM, 
while that of IRF-3 RD is 2.8 μM. In the mixture containing NTAIL + XD, the concentration of NTAIL is 3.5 μM, while that of XD 
is 7 μM. The CD spectra of XD or IRF-3 RD alone (grey lines), as well as the theoretical average curves calculated by assuming 
that no structural variations occur (see Materials and Methods) are also shown. Data are representative of one out of three 
independent experiments.
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Analysis of NTAIL and IRF3 mutual structural transitions by heteronuclear NMRFigure 5
Analysis of NTAIL and IRF3 mutual structural transitions by heteronuclear NMR. 2D-HSQC of 15N-NTAIL alone (25 μM) (in blue) or in the presence of unlabelled IRF-3 (100 μM) (in red) (A) and of 15N-IRF-3 alone (25 μM) (in blue) or in the 
presence of unlabelled N (50 μM) (in red) (B). Spectra were recorded in buffer D.
A
B
Virology Journal 2009, 6:59 http://www.virologyj.com/content/6/1/59frequencies of NTAIL were not affected by the addition of
IRF-3 RD. These data clearly indicate a lack of interaction
between NTAIL and IRF-3 RD.
In order to assess whether NTAIL was able to interact with
IRF-3 RD only in the context of the full-length, auto-
assembled nucleoprotein, a HSQC spectrum of 15N uni-
formly labeled IRF-3 RD, either alone (25 μM) or in pres-
ence of a 2-fold molar excess of full-length nucleoprotein
was also recorded. The HSQC spectrum of 15N IRF-3 RD
was typical of a folded protein, as judged on the basis of
the spread of the proton resonances in the 7 to 10 ppm
range (Figure 5B). Notably, after addition of unlabeled N,
no peak displacement was observed (Figure 5B).
In conclusion, upon mixing IRF-3 RD with either NTAIL or
the full-length nucleoprotein no magnetic perturbation of
the labeled protein was observed.
Analysis of the NTAIL- IRF-3 RD interaction by site-directed 
spin-labeling EPR spectroscopy
The ability of NTAIL to interact with IRF-3 RD was next
assessed by using site-directed spin-labeling (SDSL) EPR
spectroscopy. The basic strategy of this technique involves
the introduction of a paramagnetic nitroxide side chain at
a selected protein site. This is usually accomplished by
cysteine-substitution mutagenesis, followed by covalent
modification of the unique sulfydryl group with a selec-
tive nitroxide reagent, such as the methanethiosulfonate
(MTSL) derivative (for reviews see [43-45]). Then, EPR
spectroscopy is used to monitor variations in the mobility
of the spin label in the presence of ligands or protein part-
ners.
We thus used three spin-labeled NTAIL variants, namely
S407C, L496C and V517C, which possess a nitroxide spin
label covalently grafted at positions 407, 496 and 517,
respectively (Figure 6) [29]. We then recorded the EPR
spectra of these spin-labeled NTAIL proteins either alone
(Figure 6, solid line) or in the presence of either a four-
fold molar excess of IRF-3 RD (Figure 6, left panel, dotted
line) or of a two-fold molar excess of XD (Figure 6, right
panel, dotted line). Experiments were carried out in buffer
D, a condition where IRF-3 RD is monomeric. The addi-
tion of a two-fold molar excess of XD significantly affects
the spectral shape of the spin-labeled L496C and V517C
NTAIL variants, with strong and moderate effects, respec-
tively (Figure 6, right panel) (see also [29]). Conversely,
Analysis of NTAIL structural transitions in the presence of IRF-3 RD by EPR spectroscopyFigure 6
Analysis of NTAIL structural transitions in the presence of IRF-3 RD by EPR spectroscopy. Normalized room tem-
perature EPR spectra of three spin-labeled NTAIL proteins (20 μM) either in the absence or presence of a four-fold molar 
excess of IRF-3 RD (left panel) or in the absence or presence of a two-fold molar excess of XD (right panel). Spectra were 
recorded in buffer D. The schematic representation of each spin-labeled NTAIL protein is shown. The spin-label is highlighted.
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Virology Journal 2009, 6:59 http://www.virologyj.com/content/6/1/59no significant impact of XD on the mobility of the spin
label grafted at position 407 was observed (Figure 6, right
panel) (see also [29]), in agreement with the well-estab-
lished lack of involvement of this site in binding to XD
[38]. Notably, addition of IRF-3 RD does not trigger any
significant variation in the spectral shape in any of the
spin-labeled NTAIL variants (Figure 6, left panel), thus sup-
porting lack of involvement of the NTAIL regions close to
the spin-label in the interaction with IRF-3 RD.
Analysis of the NTAIL- IRF-3 RD interaction by intrinsic 
fluorescence spectroscopy
We next studied the possible impact of NTAIL on the fluo-
rescence emission of IRF-3 RD. While NTAIL is devoid of
trp, IRF-3 RD possesses 9 trp residues. IRF-3 RD has a max-
imum of fluorescence emission at 343 nm (data not
shown). Titration experiments were performed in buffer
D, a condition where IRF-3 RD is monomeric. Addition of
gradually increasing NTAIL concentrations (from 1 nM up
to 1 μM) did not trigger any significant variation in the
wavelength of emission or in the fluorescence intensity of
IRF-3 RD (data not shown), indicating that the chemical
environment of the trp residues of IRF-3 RD is not modi-
fied in the presence of NTAIL.
Analysis of the NTAIL-IRF-3 RD interaction in bacterial 
lysates
In order to assess whether the interaction between NTAIL
and IRF-3 RD required a cellular co-factor possibly occur-
ring in prokaryotic cells, we tested the NTAIL-IRF-3 RD
interaction in bacterial lysates by using co-immunopre-
cipitation. All experiments were carried out in buffer C,
thus ensuring a monomeric state of IRF-3 RD.
After incubating stoichiometric amounts of histidine
tagged XD with a resin coated with an anti-flag mAb and
flagged NTAIL, XD was only found in the retained fraction,
consistent with the ability of these proteins to interact
(Figure 7). Conversely, upon addition of stoichiometric
amounts of a bacterial lysate expressing histidine tagged
NTAIL to a resin coated with IRF-3 RD, NTAIL was found in
both unretained and retained fractions (Figure 7). Note
that the occurrence of unflagged NTAIL in the retained frac-
tion was not due to the ability of IRF-3 RD to co-precipi-
tate the former on the resin, but rather to the lack of a
washing step, thus leading to an equal repartition of NTAIL
in the unretained and retained fractions. These results
showed that while the monoclonal anti-flag antibodies
co-immunoprecipitated NTAIL and purified XD, they failed
to co-immunoprecipitate IRF-3 RD and NTAIL from bacte-
rial lysates.
Analysis of interaction in yeast using the two-hybrid assay
To assess whether the interaction between IRF-3 and MeV
NTAIL could require an eukaryotic cellular context, we stud-
ied this interaction in yeast using the Lex-A two hybrid
assay. The successful mating of yeast cells expressing AD-
prey and BD-bait constructs was verified by the growth in
the glucose-His-Trp + X-Gal supplemented medium (Fig-
ure 8A, left panel). Despite the expression of the protein
(Figure 8B), the full length IRF-3 fused to Lex-A-activating
domain (AD-IRF-3) did not react with any of the BD-NTAIL
constructs (Figure 8A) as shown by lack of growth in
galactose/raffinose -His-Ura-Trp + X-Gal medium and
lack of the reporter β-galactosidase enzymatic activity. As
controls, an AD-peptide aptamer anti-LexA (Ctr+), but not
an irrelevant AD-aptamer (Ctr-), reacted with all Lex-A-
baits, while AD-PCT reacted only with BD-NTAIL, BD-NΔ1
and BD-NΔN3, and not with BD-Ø or with BD-NΔ2,3 as
expected.
Discussion
We herein report the bacterial purification of the regula-
tory domain of IRF-3 and showed that the buffer condi-
tions strongly affect its oligomerization state. Indeed, the
protein was shown to exist in either a dimeric or mono-
meric state depending on the buffer and the ionic
strength. Since MeV N was reported to trigger the phos-
phorylation-dependent dimerization of IRF-3 [24,32], we
reasoned that the dimeric form of this latter might in prin-
ciple be expected to exhibit a reduced or null ability to
interact with NTAIL. This hypothesis was indeed experi-
mentally confirmed, where various spectroscopic
Co-immunoprecipitation by an anti-flag mAbFigure 7
Co-immunoprecipitation by an anti-flag mAb. 
Coomassie blue staining of a 18% SDS-PAGE. Bacterial 
lysates expressing flagged NTAIL, flagged IRF-3 RD, or histi-
dine-tagged NTAIL were used. Purified unflagged XD was also 
used. Fl-t: flow-through (unretained fraction). R: retained 
fraction. Arrowheads show the light and heavy chains of the 
mAb, which are visible on the gel at around 25 and 55 kDa, 
respectively. Numbers 1 to 3 highlight IRF-3 RD, NTAIL and 
XD bands, respectively.
    
    
    Page 12 of 17
(page number not for citation purposes)
Virology Journal 2009, 6:59 http://www.virologyj.com/content/6/1/59approaches failed to detect an interaction between NTAIL
and the dimeric form of IRF-3 RD (data not shown). We
therefore searched for conditions where IRF-3 RD was
found to be a stable monomer up to protein concentra-
tions as high as 1 mM. We then used the monomeric form
of IRF-3 RD for a thorough analysis of its ability to interact
with NTAIL. Using various spectroscopic approaches, we
failed to point out any detectable interaction between IRF-
3 RD and NTAIL under conditions where this latter interacts
with the X domain of the phosphoprotein
Lack of deviations of the experimentally observed CD
spectrum of an NTAIL/IRF-3 RD mixture from the average
CD spectrum can be accounted for by assuming that either
NTAIL does not interact with IRF-3 RD under these experi-
mental conditions, or that their interaction does not
imply any significant, concomitant structural rearrange-
ment. It should be pointed out that this spectroscopic
approach has been already shown to be sensitive enough
to unveil α-helical transitions involving as few as 17 NTAIL
residues out of 125 [26,28] (see also Figure 3B). That CD
was sensitive enough to detect a possible NTAIL folding of
the same extent as that observed in the presence of XD,
was checked and confirmed by the fact that the experi-
mentally observed CD spectrum of a 1:2 mixture of NTAIL
and IRF-3 RD significantly deviates from a simulated CD
spectrum corresponding to a 1:2 mixture of "folded" NTAIL
and IRF-3 RD. The CD spectrum of "folded" NTAIL was cal-
culated from the CD spectrum of a mixture containing
NTAIL and XD in the 1:2 molar ratio upon subtraction of
the XD contribution (data not shown).
On the other hand, in CD experiments, inability of IRF-3
RD to interact with NTAIL could arise either from possible
dimerization of IRF-3 RD in sodium phosphate buffer,
with subsequent loss of binding ability, or from the use of
protein concentrations below the actual KD. Indeed, while
the NTAIL and XD concentrations (3.5 and 7 μM, respec-
Analysis of IRF-3 and NTAIL interaction in yeastFigure 8
Analysis of IRF-3 and NTAIL interaction in yeast. (A) Yeast growth and X-gal expression after co-transformation with 
bait-LexA and BD-prey encoding plasmid in glucose -His-Trp + X-Gal and in galactose/raffinose -His-Ura-Trp + X-Gal medium. 
(B) IRF-3-LexA and PCT-LexA expression level in yeast detected by western blot using anti-HA mAb. Ctr+ is the anti-LexA 
peptide aptamer RG22C, Ctr- is the irrelevant peptide aptamer C5C. Ø indicates LexA alone.
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Virology Journal 2009, 6:59 http://www.virologyj.com/content/6/1/59tively) are well above the reported KD (100 nM) [38], the
KD between NTAIL and IRF-3 RD is not known. Hence, the
experimentally used NTAIL and IRF-3 RD concentrations
(1.4 and 2.8 μM, respectively) might be not high enough
to allow a productive interaction.
In order to circumvent these problems, we carried out
NMR experiments, which allowed both use of buffer D, a
condition where IRF-3 RD was shown to be monomeric,
and of protein concentrations as high as 100 μM. Under
these conditions, no interaction was detected between
IRF-3 RD and either NTAIL or the full-length nucleoprotein.
Lack of interaction with N ruled out the possibility that
IRF-3 RD might interact with NTAIL only in the context of
a self-assembled nucleocapsid-like structure. Noteworthy,
using comparable protein concentrations, heteronuclear
NMR has already been proven to be sensitive enough to
document the XD-induced folding of NTAIL, where from a
total of 125 residues, 11 were shown to undergo an α-hel-
ical transition and seven a less dramatic conformational
change [38]. The NTAIL-XD interaction is however charac-
terized by a high affinity, with an estimated KD of 100 nM
[38]. We could speculate that if the NTAIL-IRF-3 RD bind-
ing affinity is much weaker, then this would result in little
complex formation, thus escaping detection. However, it
should be pointed out that heteronuclear NMR has been
already proven to be sensitive enough to document pro-
tein-protein interactions characterized by KD values up to
the mM range (for a review see [46]). Notably, using pro-
tein concentrations similar to those used in this study,
heteronuclear NMR successfully unveiled the weak-affin-
ity interaction (KD 10 μM) between the intrinsically disor-
der cyclin-dependent inhibitor p21 and Cdk2 [47].
Furthermore, if we assume that in HSQC experiments the
percentage of the NTAIL/IRF-3 RD complex is as low as
10%, which could indeed escape detection, then the cor-
responding calculated KD would be approximately 0.9
mM, based on the following equation
A KD in the mM range would support a fortuitous interac-
tion at best, assuming an IRF-3 intracellular concentration
of approximately 1 μM, as calculated assuming an overall
intracellular protein concentration of 200 mg/ml and that
IRF-3 represents approximately 1/4000 of total cellular
proteins [48].
Using SDSL EPR spectroscopy and a monomeric form of
IRF-3 RD, we failed to point out an impact of this latter on
the mobility of three spin labels grafted within NTAIL.
These results support a lack of involvement of the three
spin-labeled sites in the interaction and/or a lack of inter-
action between NTAIL and IRF-3 RD. Although this former
hypothesis could not be formally ruled out, the spin
labels are located within three NTAIL regions that can be
expected to be involved in the possible interaction with
IRF-3 RD, since they are conserved within Morbillivirus
members [49] and have been shown to play a functional
role in the molecular partnership of NTAIL: indeed, Box1 is
involved in the interaction with a yet unidentified nucle-
oprotein cellular receptor [22,23], while Box2 and Box3
participate to binding to both Hsp72 [20,21] and XD
[28,29,38]. Besides, it is worthy to mention that spin-label
EPR spectroscopy has already been proven to be well
suited to monitor low-affinity interactions, such as bind-
ing of spin-labeled ATP to the multi-drug resistance P-
glycoprotein that is characterized by a KD of approxi-
mately 700 μM [50].
Lack of NTAIL impact on the intrinsic trp fluorescence of
IRF-3 RD could reflect either a lack of interaction between
the proteins, or a location of the IRF-3 RD trp residues
outside the region of interaction. This latter hypothesis is
however unlikely, since the 9 trp residues are scattered on
the whole IRF-3 RD surface (see Figure 1B), with two of
them being located in the proximity of the triple α-helical
bundle that is supposed to correspond to the putative
binding site, based on its similarity to the XD structure
(see pdb file 1QWT) and on its involvement in the bind-
ing of the (otherwise disordered) IBiD domain of CREB
(see pdb file 1ZOQ). Taking into account the fact that flu-
orescence spectroscopy has been already successfully used
to monitor the interaction between XD and a single-site
tryptophan-substituted NTAIL variant [38] and has also
been reported to be able to unveil weak affinity interac-
tions with a KD in the 20–30 μM range [51], these data
argue for a lack of direct interaction between IRF-3 RD and
NTAIL.
Since co-immunoprecipitation experiments carried out by
both tenOever et al. [24] and ourselves, suggest that N and
IRF-3 interact somehow, the hypothesis can be drawn that
a specific cellular context is required for the interaction to
occur. We therefore questioned whether a bacterial lysate
could provide such a context. The interaction was thus
tested in crude E. coli lysates using a co-immunoprecipita-
tion protocol in which no washing step was carried out, a
method derived from the "hold-up" technique that is well
adapted for the detection of low-affinity interactions with
KD values as high as 50 μM [52]. Notably, and in spite of
the fact that the experimental design was in principle
expected to allow documentation of low-affinity and
kinetically transient complexes, no interaction could be
detected. Likewise, using the yeast two-hybrid assay, an
approach that has been already successfully used to docu-
ment MeV protein-protein interactions [42], no interac-
tion was detected in the yeast cellular context either.
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Altogether, the results herein presented indicate that the
NTAIL-IRF-3 interaction requires a specific eukaryotic cellu-
lar environment, such as that provided by 293T cells. That
a specific cellular context is required for efficient MeV
RNA synthesis has been already reported [53] and argue
for the requirement of unknown cellular co-factor(s) in
conferring competence for both transcription and replica-
tion to viral nucleocapsids. In the case of the NTAIL-IRF-3
interaction, the strict dependence from a particular cellu-
lar context may reflect the requirement of either a human-
or mammalian-specific post-translational modification of
one or both interactors, or of a human or mammalian cel-
lular co-factor, which would act as a bridge thereby pro-
moting the N-IRF-3 association. In support of this last
hypothesis, intrinsically disordered proteins are known to
often display weak affinities towards their partners [7,15],
thus leading to complexes that are not stable by them-
selves and must be strengthened by the combination of
other interactions or by multimerization (for examples
within the replicative complex of MeV see [54]). In further
support of the requirement for a cellular co-factor, tenO-
ever et al. found that the N protein associated with both
IRF-3 and the IRF-3 virus-activated kinase suggesting that
both proteins are part of a large complex that favors the
colocalization of the kinase and of its substrate [24]. In
addition, as MeV infection (or MeV N transfection) trig-
gers binding of IRF-3 to the CREB binding protein to form
a complex that activates target genes in the nucleus
[24,55], it is also possible that recognition of N by IRF-3
could be promoted by the CREB binding protein.
Preparative co-immunoprecipitation experiments cou-
pled to mass spectrometry are in progress in view of either
ascertaining a role for the virus-activated kinase or the
CREB binding protein, or identifying a possible cellular
co-factor distinct from these two latter cellular proteins.
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